NO20091423L - Pyrimidinderivater og deres anvendelse som kinaseinhibitorer - Google Patents
Pyrimidinderivater og deres anvendelse som kinaseinhibitorerInfo
- Publication number
- NO20091423L NO20091423L NO20091423A NO20091423A NO20091423L NO 20091423 L NO20091423 L NO 20091423L NO 20091423 A NO20091423 A NO 20091423A NO 20091423 A NO20091423 A NO 20091423A NO 20091423 L NO20091423 L NO 20091423L
- Authority
- NO
- Norway
- Prior art keywords
- kinase inhibitors
- pyrimidine derivatives
- pyrimidine
- derivatives
- kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84383606P | 2006-09-11 | 2006-09-11 | |
PCT/US2007/078154 WO2008033834A1 (en) | 2006-09-11 | 2007-09-11 | Pyrimidines derivatives and their use as kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20091423L true NO20091423L (no) | 2009-06-10 |
Family
ID=38884547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20091423A NO20091423L (no) | 2006-09-11 | 2009-04-07 | Pyrimidinderivater og deres anvendelse som kinaseinhibitorer |
Country Status (18)
Country | Link |
---|---|
US (1) | US20080125417A1 (no) |
EP (1) | EP2069314A1 (no) |
JP (1) | JP2010502749A (no) |
KR (1) | KR20090061655A (no) |
CN (1) | CN101605766A (no) |
AR (1) | AR063946A1 (no) |
AU (1) | AU2007296550A1 (no) |
BR (1) | BRPI0716888A2 (no) |
CA (1) | CA2661938A1 (no) |
CL (1) | CL2007002641A1 (no) |
IL (1) | IL197231A0 (no) |
MX (1) | MX2009002648A (no) |
NO (1) | NO20091423L (no) |
PE (1) | PE20081059A1 (no) |
RU (1) | RU2009113691A (no) |
TW (1) | TW200829577A (no) |
WO (1) | WO2008033834A1 (no) |
ZA (1) | ZA200901593B (no) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2701275C (en) | 2007-10-23 | 2016-06-21 | F. Hoffmann-La Roche Ag | Kinase inhibitors |
ES2554615T3 (es) * | 2008-05-06 | 2015-12-22 | Gilead Connecticut, Inc. | Amidas sustituidas, método de preparación y utilización como inhibidores de Btk |
BR112013006016A2 (pt) | 2010-09-15 | 2016-06-07 | Hoffmann La Roche | compostos de azabenzotiazol, composições e métodos de uso |
EP2665711A1 (en) * | 2011-01-21 | 2013-11-27 | Abbvie Inc. | Picolinamide inhibitors of kinases |
CN103889962B (zh) * | 2011-04-01 | 2017-05-03 | 犹他大学研究基金会 | 作为受体酪氨酸激酶btk抑制剂的取代的n‑(3‑(嘧啶‑4‑基)苯基)丙烯酰胺类似物 |
HUE059230T2 (hu) * | 2011-06-10 | 2022-10-28 | Merck Patent Gmbh | Vegyületek és eljárások BTK-inhibitor aktivitású pirimidin és piridin vegyületek elõállítására |
CN103732596B (zh) | 2011-07-08 | 2016-06-01 | 诺华股份有限公司 | 吡咯并嘧啶衍生物 |
CN103073508B (zh) | 2011-10-25 | 2016-06-01 | 北京大学深圳研究生院 | 激酶抑制剂及治疗相关疾病的方法 |
US9782406B2 (en) | 2011-10-25 | 2017-10-10 | Peking University Shenzhen Graduate School | Kinase inhibitor and method for treatment of related diseases |
ES2552514T3 (es) | 2011-11-03 | 2015-11-30 | Hoffmann-La Roche Ag | Compuestos bicíclicos de piperazina |
PE20141686A1 (es) | 2011-11-03 | 2014-11-08 | Hoffmann La Roche | Compuestos de piperazina alquilados como inhibidores de actividad btk |
RU2622391C2 (ru) | 2011-11-03 | 2017-06-15 | Ф. Хоффманн-Ля Рош Аг | Соединения 8-фторфталазин-1(2н)-она в качестве ингибиторов тирозинкиназы брутона |
UA111756C2 (uk) | 2011-11-03 | 2016-06-10 | Ф. Хоффманн-Ля Рош Аг | Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона |
RU2014126750A (ru) * | 2011-12-09 | 2016-01-27 | Ф. Хоффманн-Ля Рош Аг | Ингибиторы тирозинкиназы брутона |
US9365566B2 (en) | 2012-03-27 | 2016-06-14 | Takeda Pharmaceutical Company Limited | Cinnoline derivatives |
US9013997B2 (en) | 2012-06-01 | 2015-04-21 | Broadcom Corporation | System for performing distributed data cut-through |
JP6575950B2 (ja) | 2012-07-24 | 2019-09-18 | ファーマサイクリックス エルエルシー | Bruton型チロシンキナーゼ(Btk)阻害剤に対する耐性を伴う変異 |
JO3377B1 (ar) | 2013-03-11 | 2019-03-13 | Takeda Pharmaceuticals Co | مشتقات بيريدينيل وبيريدينيل مندمج |
CN104109127B (zh) * | 2013-04-19 | 2019-11-05 | 北京大学深圳研究生院 | 激酶抑制剂及治疗相关疾病的方法 |
ES2619125T3 (es) | 2013-04-25 | 2017-06-23 | Beigene, Ltd. | Compuestos heterocíclicos fusionados como inhibidores de proteína cinasa |
KR101815360B1 (ko) | 2013-07-03 | 2018-01-04 | 에프. 호프만-라 로슈 아게 | 헤테로아릴 피리돈 및 아자-피리돈 아마이드 화합물 |
CN105745202A (zh) * | 2013-09-03 | 2016-07-06 | 卡尔那生物科学株式会社 | 新型2,6-二氨基嘧啶衍生物 |
JP6623353B2 (ja) | 2013-09-13 | 2019-12-25 | ベイジーン スウィッツァーランド ゲーエムベーハー | 抗pd−1抗体並びにその治療及び診断のための使用 |
SI3052476T1 (sl) | 2013-09-30 | 2020-12-31 | Guangzhou Innocare Pharma Tech Co., Ltd. | Substituirani nikotinimidni inhibitorji BTK in njihova priprava in uporaba pri zdravljenju raka, vnetja in avtoimunske bolezni |
US9512084B2 (en) * | 2013-11-29 | 2016-12-06 | Novartis Ag | Amino pyrimidine derivatives |
CA2929918C (en) | 2013-12-05 | 2018-01-23 | F. Hoffmann-La Roche Ag | Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality |
MX370103B (es) * | 2013-12-11 | 2019-12-02 | Biogen Ma Inc | Compuestos de biarilo utiles para el tratamiento de enfermedades humanas en oncologia, neurologia e inmunologia. |
JP6526189B2 (ja) | 2014-07-03 | 2019-06-05 | ベイジーン リミテッド | 抗pd−l1抗体並びにその治療及び診断のための使用 |
WO2016079669A1 (en) * | 2014-11-19 | 2016-05-26 | Novartis Ag | Labeled amino pyrimidine derivatives |
ES2913494T3 (es) | 2016-02-29 | 2022-06-02 | Hoffmann La Roche | Composiciones de forma farmacéutica que comprenden un inhibidor de tirosina cinasa de Bruton |
AU2017240609B2 (en) | 2016-03-31 | 2021-07-15 | Takeda Pharmaceutical Company Limited | Isoquinolinyl triazolone complexes |
CN109475536B (zh) | 2016-07-05 | 2022-05-27 | 百济神州有限公司 | 用于治疗癌症的PD-l拮抗剂和RAF抑制剂的组合 |
CN109563099B (zh) | 2016-08-16 | 2023-02-03 | 百济神州有限公司 | 一种化合物的晶型、其制备和用途 |
AU2017313085A1 (en) | 2016-08-19 | 2019-03-14 | Beigene Switzerland Gmbh | Use of a combination comprising a Btk inhibitor for treating cancers |
JP2019529419A (ja) | 2016-09-19 | 2019-10-17 | エムイーアイ ファーマ,インク. | 併用療法 |
CN110461847B (zh) | 2017-01-25 | 2022-06-07 | 百济神州有限公司 | (S)-7-(1-(丁-2-炔酰基)哌啶-4-基)-2-(4-苯氧基苯基)-4,5,6,7-四氢吡唑并[1,5-a]嘧啶-3-甲酰胺的结晶形式、其制备及用途 |
TW201836642A (zh) | 2017-03-24 | 2018-10-16 | 美商建南德克公司 | 治療自體免疫及發炎疾病的方法 |
CA3066518A1 (en) | 2017-06-26 | 2019-01-03 | Beigene, Ltd. | Immunotherapy for hepatocellular carcinoma |
CN110997677A (zh) | 2017-08-12 | 2020-04-10 | 百济神州有限公司 | 具有改进的双重选择性的Btk抑制剂 |
WO2019108795A1 (en) | 2017-11-29 | 2019-06-06 | Beigene Switzerland Gmbh | Treatment of indolent or aggressive b-cell lymphomas using a combination comprising btk inhibitors |
WO2023080732A1 (ko) * | 2021-11-05 | 2023-05-11 | 주식회사 유빅스테라퓨틱스 | Btk 단백질 분해 활성을 갖는 화합물 및 이들의 의약 용도 |
US11786531B1 (en) | 2022-06-08 | 2023-10-17 | Beigene Switzerland Gmbh | Methods of treating B-cell proliferative disorder |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0014022D0 (en) * | 2000-06-08 | 2000-08-02 | Novartis Ag | Organic compounds |
US7429599B2 (en) * | 2000-12-06 | 2008-09-30 | Signal Pharmaceuticals, Llc | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
GB0103926D0 (en) * | 2001-02-17 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
TWI329105B (en) * | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
ATE454378T1 (de) * | 2002-11-01 | 2010-01-15 | Vertex Pharma | Verbindungen, die sich als inhibitoren vonjak und anderen proteinkinasen eignen |
US20050014753A1 (en) * | 2003-04-04 | 2005-01-20 | Irm Llc | Novel compounds and compositions as protein kinase inhibitors |
AU2004261484A1 (en) * | 2003-07-30 | 2005-02-10 | Cyclacel Limited | 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
AU2004278413B2 (en) * | 2003-09-30 | 2008-07-31 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
AU2005295788A1 (en) * | 2004-10-13 | 2006-04-27 | Wyeth | N-benzenesulfonyl substituted anilino-pyrimidine analogs |
AU2005309732A1 (en) * | 2004-11-23 | 2006-06-01 | Celgene Corporation | JNK inhibitors for treatment of CNS injury |
KR20080110998A (ko) * | 2006-01-30 | 2008-12-22 | 엑셀리시스, 인코포레이티드 | Jak2 조절자로서 4아릴2아미노피리미딘 또는 4아릴2아미노알킬피리미딘 및 이들을 포함하는 약제학적 조성물 |
-
2007
- 2007-09-10 AR ARP070103990A patent/AR063946A1/es unknown
- 2007-09-11 WO PCT/US2007/078154 patent/WO2008033834A1/en active Application Filing
- 2007-09-11 CA CA002661938A patent/CA2661938A1/en not_active Abandoned
- 2007-09-11 JP JP2009527622A patent/JP2010502749A/ja active Pending
- 2007-09-11 PE PE2007001218A patent/PE20081059A1/es not_active Application Discontinuation
- 2007-09-11 KR KR1020097007472A patent/KR20090061655A/ko not_active Application Discontinuation
- 2007-09-11 EP EP07814805A patent/EP2069314A1/en not_active Withdrawn
- 2007-09-11 CL CL200702641A patent/CL2007002641A1/es unknown
- 2007-09-11 TW TW096133933A patent/TW200829577A/zh unknown
- 2007-09-11 RU RU2009113691/04A patent/RU2009113691A/ru not_active Application Discontinuation
- 2007-09-11 AU AU2007296550A patent/AU2007296550A1/en not_active Abandoned
- 2007-09-11 US US11/853,488 patent/US20080125417A1/en not_active Abandoned
- 2007-09-11 MX MX2009002648A patent/MX2009002648A/es not_active Application Discontinuation
- 2007-09-11 BR BRPI0716888-8A patent/BRPI0716888A2/pt not_active Application Discontinuation
- 2007-09-11 CN CNA2007800418203A patent/CN101605766A/zh active Pending
-
2009
- 2009-02-24 IL IL197231A patent/IL197231A0/en unknown
- 2009-03-05 ZA ZA200901593A patent/ZA200901593B/xx unknown
- 2009-04-07 NO NO20091423A patent/NO20091423L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2007296550A1 (en) | 2008-03-20 |
US20080125417A1 (en) | 2008-05-29 |
CN101605766A (zh) | 2009-12-16 |
JP2010502749A (ja) | 2010-01-28 |
WO2008033834A1 (en) | 2008-03-20 |
BRPI0716888A2 (pt) | 2013-10-22 |
CA2661938A1 (en) | 2008-03-20 |
RU2009113691A (ru) | 2010-10-20 |
PE20081059A1 (es) | 2008-10-22 |
KR20090061655A (ko) | 2009-06-16 |
ZA200901593B (en) | 2010-03-31 |
CL2007002641A1 (es) | 2008-06-20 |
AR063946A1 (es) | 2009-03-04 |
IL197231A0 (en) | 2009-12-24 |
MX2009002648A (es) | 2009-03-26 |
EP2069314A1 (en) | 2009-06-17 |
TW200829577A (en) | 2008-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20091423L (no) | Pyrimidinderivater og deres anvendelse som kinaseinhibitorer | |
DK2099447T3 (da) | Imidazotriaziner og imidazopyrimidiner som kinaseinhibitorer | |
DK2261223T3 (da) | Pyrimidinderivater anvendt som PI-3-kinasehæmmere | |
NO20082514L (no) | Aminopyrimidiner anvendelige som kinaseinhibitorer | |
DK1761505T3 (da) | Pyrimidin-urinstof-derivater som kinaseinhibitorer | |
DK2132194T3 (da) | Substituerede isoquinoliner og deres anvendelse som Rho-kinase inhibitorer | |
DK2049557T3 (da) | 1-(-D-glycopyranosyl)-3-(4-cyclopropylphenylmethyl)-4-halogenindolderivater og anvendelse heraf som sglt-inhibitorer | |
NO20084764L (no) | Tioksantinderivater og deres anvendelse som MPO inhibitorer | |
DK1841757T3 (da) | Heteroaromatiske quinolin-forbindelser og deres anvendelse som PDE10-hæmmere | |
CR10369A (es) | Pyrimidine derivatives as pi3k inhibitors | |
NO20084533L (no) | Pyrimidin-derivat som PI3K-inhibitor og bruk av dette | |
DK1763517T3 (da) | Pyrimidinderivater som 11beta-HSD1-inhibitorer | |
DK1926722T3 (da) | Substituerede benzimidazoler som kinaseinhibitorer | |
DK2252597T3 (da) | Pyrazinderivater og deres anvendelse som proteinkinaseinhibitorer | |
DK1979326T3 (da) | Pyridin- og pyrimidinderivater som inhibitorer af histondeacetylase | |
DK2220070T3 (da) | 2-benzylpyridazinonderivater som Met-kinaseinhibitorer | |
HK1146042A1 (en) | Pyrimidine derivatives as protein kinase inhibitors | |
DK2848610T3 (da) | Hæmmere af kinaseaktivitet | |
BRPI0716781A2 (pt) | Inibidores da quinase | |
DK1943243T3 (da) | Kinase-inhibitorer | |
DK1723135T3 (da) | Kendte hydroxy-6-heteroarylphenanthridiner og deres anvendelse som pde4-inhibitorer | |
ATE433449T1 (de) | Kinaseinhibitoren | |
ATE520664T1 (de) | Tyrosinkinase-hemmer | |
DK2148876T3 (da) | Pyrazolonderivater som PDE4-inhibitorer | |
NO20084739L (no) | Substituerte 3-cyanopyridiner som protein kinase inhibitorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |